Chemical Compound
20(R)-Ginsenoside Rg2
CAS Registry Number
80952-72-3
Primary Record
20(R)-Ginsenoside Rg2
- In stock
- 9,854 g
- Purity
- 99.7 %
- CAS
- 80952-72-3
Compound Identifiers & Properties
- CAS
- 80952-72-3
- PubChem CID
- 75412551
- SMILES
- C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2O[C@H]3C[C@@]4([C@H](C[C@H]([C@H]5[C@]4(CC[C@@H]5[C@@](C)(CCC=C(C)C)O)C)O)[C@@]6([C@@H]3C([C@H](CC6)O)(C)C)C)C)CO)O)O)O)O)O
- Canonical SMILES
- CC(C)=CCC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)C[C@]12C
Names & Synonyms
- 20(R)-Ginsenoside Rg2
- 20R-Ginsenoside Rg2
- Ginsenoside RG2
- Notoginsenoside Rg1
- (S)Ginsenoside Rg2
- Notoginsenoside Rg2
- R-Ginsenoside Rg2
- 80952-72-3
- 20(R)Ginsenoside Rg2
- beta-D-glucopyranoside
- (R)-Ginsenoside Rg2
- (20R)-Ginsenoside Rg2
- RefChem:89610
- orb1303688
- CHEMBL3357159
- SCHEMBL29929192
- HY-N2039
- C42H72O13
- MSK157338
- AKOS027251122
- ZINC255193203
- ACN-056814
- EBC-615744
- FG73798
- AC-34690
- DA-69709
- MS-31436
- PD125601
- AB0035627
- J466.393D
- CS-0018529
- FT-0699012
- FT-0777163
- Y0007
- (20R)-GINSENOSIDE RG2 (REFERENCE GRADE)
- A901586
- (2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2R)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol
- (2S,3R,4R,5R,6S)-2-{[(2R,3R,4S,5S,6R)-2-{[(1S,3aR,3bR,5S,5aR,7S,9aR,9bR,11R,11aR)-7,11-dihydroxy-1-[(2R)-2-hydroxy-6-methylhept-5-en-2-yl]-3a,3b,6,6,9a-pentamethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-5-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol
- (20R)-3beta,12beta,20-Trihydroxy-6alpha-(2-O-alpha-L-rhamnopyranosyl-beta-D-glucopyranosyloxy)dammara-24-ene
- (20R)-6alpha-[2-O-(alpha-L-Rhamnopyranosyl)-beta-D-glucopyranosyloxy]-3beta,12beta,20-trihydroxydammara-24-ene
- (2S,3R,4R,5R,6S)-2-{[(2R,3R,4S,5S,6R)-2-{[(1S,3AR,3BR,5S,5AR,7S,9AR,9BR,11R,11AR)-7,11-DIHYDROXY-1-[(2R)-2-HYDROXY-6-METHYLHEPT-5-EN-2-YL]-3A,3B,6,6,9A-PENTAMETHYL-DODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-5-YL]OXY}-4,5-DIHYDROXY-6-(HYDROXYMETHYL)OXAN-3-YL]OXY}-6-METHYLOXANE-3,4,5-TRIOL
- [(20R)-3beta,12beta,20-Trihydroxydammar-24-en-6alpha-yl]2-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside
- 2-[2-[[3,12-dihydroxy-17-(2-hydroxy-6-methylhept-5-en-2-yl)-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol
- 20R-Ginsenoside Rg2(S)Ginsenoside Rg2; (2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2R)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol; R-Ginsenoside Rg2
- beta-D-Glucopyranoside, (3beta,6alpha,12beta,20R)-3,12,20-trihydroxydammar-24-en-6-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-
- GF VII; (3ss,6a,12ss,20R)-3,12,20-Trihydroxydammar-24-en-6-yl 2-O-(6-deoxy-a-L-mannopyranosyl)-ss-D-glucopyranoside